Intrathecal baclofen treatment in dystonic cerebral palsy: A randomized clinical trial.
Completed
- Conditions
- dystonia, dyskinesia, dystonic cerebral palsy, dyskinetc cerebral palsy, cerebral palsy, intrathecal baclofen, ITB
- Registration Number
- NL-OMON21127
- Lead Sponsor
- VU University Medical CenterMaastricht University Medical Center
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
1. Dystonic cerebral palsy;
2. Gross Motor Functioning Classification System (GMFCS) level IV or V;
Exclusion Criteria
1. Contra-indications for general anesthesia;
2. Contra-indications for baclofen;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Goal Attainment Scaling.
- Secondary Outcome Measures
Name Time Method 1. Pediatric Evaluation of Disability Inventory;<br /><br>2. Barry Albright Dystonia Scale;<br /><br>3. Dyskinesia Impairment Scale;<br /><br>4. Electromyography;<br /><br>5. H-reflex;<br /><br>6. Visual Analogue Scale for pain and comfort.